Beclometason/Formoterol Cipla inhaler

Beclometason/Formoterol Cipla is a prescription pharmaceutical used primarily for the treatment of respiratory conditions such as asthma or COPD. This specific product is a combination medication delivered through a pressurized inhalation solution. The brand Cipla has its roots in India, where it was founded in 1935 with the goal of making India self-reliant in healthcare.

Today, Cipla is a major global pharmaceutical player. While it has a significant presence in Europe through subsidiaries like Cipla Europe NV (based in Belgium), the primary manufacturing and development hubs remain in India. The company continues to be owned by the Cipla Limited group, which is headquartered in Mumbai, India, and is publicly traded on Indian stock exchanges. It serves as one of the world's largest generic drug manufacturers.